Home › Funds › READYSTATE ASSET MANAGEMENT LP › LMAT
READYSTATE ASSET MANAGEMENT LP position in LMAT
LEMAITRE VASCULAR INC COM · Health Care
READYSTATE ASSET MANAGEMENT LP reported holding 20,000,000 shares of LMAT (LEMAITRE VASCULAR INC COM) in its Q2 2026 13F filing — a position valued at US$21.3M, representing 1.03% of its reported portfolio and ranking #24 among its reported holdings. READYSTATE ASSET MANAGEMENT LP has disclosed LMAT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How READYSTATE ASSET MANAGEMENT LP's LMAT position evolved
READYSTATE ASSET MANAGEMENT LP first disclosed a stake in LMAT in Q4 2025 at 25,750,000 shares (US$25.8M). Across 3 filings, READYSTATE ASSET MANAGEMENT LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 20,000,000 shares valued at US$21.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 25.75M | $25.81M | New |
| Q1 2026 | 20.00M | $22.68M | Reduce |
| Q2 2026 | 20.00M | $21.26M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LMAT and 13F data
LMAT (LEMAITRE VASCULAR INC COM) is a Health Care company. 39 other funds we track also report a position in LMAT — the largest reported positions include Conestoga Capital Advisors, LLC (US$131.2M), Copeland Capital Management, LLC (US$76.3M), GENEVA CAPITAL MANAGEMENT LLC (US$56.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LMAT
- Conestoga Capital Advisors, LLC 1.37M sh · $131.23M · Q2 2026
- Copeland Capital Management, LLC 924.08K sh · $76.32M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 589.06K sh · $56.53M · Q2 2026
- Ranger Investment Management, L.P. 219.31K sh · $21.04M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 189.91K sh · $18.22M · Q2 2026
- Grandeur Peak Global Advisors, LLC 161.01K sh · $15.45M · Q2 2026
More on READYSTATE ASSET MANAGEMENT LP
FAQ
How long has READYSTATE ASSET MANAGEMENT LP held LMAT?
READYSTATE ASSET MANAGEMENT LP has disclosed LMAT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is READYSTATE ASSET MANAGEMENT LP's current position in LMAT?
As of Q2 2026, READYSTATE ASSET MANAGEMENT LP holds 20.00M shares of LMAT (LEMAITRE VASCULAR INC COM), valued at $21.26M, representing 1.03% of its reported portfolio and ranking #24.
Has READYSTATE ASSET MANAGEMENT LP been buying or selling LMAT?
In the latest 13F filing (Q2 2026), READYSTATE ASSET MANAGEMENT LP held unchanged its position in LMAT.
Which other funds hold LMAT?
Other major institutional holders of LMAT include Conestoga Capital Advisors, LLC, Copeland Capital Management, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.